- Adults (greater than or equal to 18 years of age) with biopsy-proven or suspected prostate cancer (elevated PSA or abnormal digital rectal exam (DRE)) who require and are willing to undergo diagnostic or therapeutic intervention as part of their diagnosis, standard of care treatment, or follow-up/surveillance for their neoplasm.